Ciprofloxacin-mediated mutagenesis is suppressed by subinhibitory concentrations of amikacin in Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy

Volumn 61, Issue 3, 2017, Pages

  Valencia, Estela Ynés ^a   Esposito, Fernanda ^a   Spira, Beny ^a   Blázquez, Jesús ^b,c   Galhardo, Rodrigo S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Instituto de Biomedicina de Sevilla   (Spain)

^c CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

Ciprofloxacin; Pseudomonas aeruginosa; recA; SOS response

Indexed keywords

AMIKACIN; CIPROFLOXACIN; GENTAMICIN; ANTIINFECTIVE AGENT; LUCIFERASE; RECA PROTEIN;

ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BROTH DILUTION; DNA REPAIR; FRACTIONAL INHIBITORY CONCENTRATION INDEX; GENE EXPRESSION; GENE INACTIVATION; MUTAGENESIS; MUTAGENIC ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; QUANTITATIVE ANALYSIS; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DISK DIFFUSION; DRUG EFFECTS; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MUTATION; PLASMID; REPORTER GENE; SOS RESPONSE (GENETICS);

AMIKACIN; ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; DISK DIFFUSION ANTIMICROBIAL TESTS; GENE EXPRESSION; GENES, REPORTER; LUCIFERASES; MUTAGENESIS; MUTATION; PLASMIDS; PSEUDOMONAS AERUGINOSA; REC A RECOMBINASES; SOS RESPONSE (GENETICS);

EID: 85014107159     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02107-16     Document Type: Article

References (33)

1. Rodríguez-Rojas A, Rodríguez-Beltrán J, Couce A, Blázquez J. 2013. Antibiotics and antibiotic resistance: a bitter fight against evolution. Int J Med Microbiol 303:293-297. https://doi.org/10.1016/j.ijmm.2013.02.004.
2. Blázquez J, Couce A, Rodríguez-Beltrán J, Rodríguez-Rojas A. 2012. Antimicrobials as promoters of genetic variation. Curr Opin Microbiol 15:561-569. https://doi.org/10.1016/j.mib.2012.07.007.
3. Power EGM, Phillips I. 1992. Induction of the SOS gene (umuC) by 4-quinolone antibacterial drugs. J Med Microbiol 36:78-82. https://doi.org/10.1099/00222615-36-2-78.
4. Cirz RT, O'Neill BM, Hammond JA, Head SR, Romesberg FE. 2006. Defining the Pseudomonas aeruginosa SOS response and its role in the global response to the antibiotic ciprofloxacin. J Bacteriol 188:7101-7110. https://doi.org/10.1128/JB.00807-06.
5. Blázquez J, Gómez-Gómez J-M, Oliver A, Juan C, Kapur V, Martín S. 2006. PBP3 inhibition elicits adaptive responses in Pseudomonas aeruginosa. Mol Microbiol 62:84-99. https://doi.org/10.1111/j.1365-2958.2006.05366.x.
6. Drlica K, Zhao X. 1997. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev 61:377-392.
7. Drlica K, Malik M, Kerns RJ, Zhao X. 2008. Quinolone-mediated bacterial death. Antimicrob Agents Chemother 52:385-392. https://doi.org/10.1128/AAC.01617-06.
8. Sanders LH, Rockel A, Lu H, Wozniak DJ, Sutton MD. 2006. Role of Pseudomonas aeruginosa dinB-encoded DNA polymerase IV in mutagenesis. J Bacteriol 188:8573-8585. https://doi.org/10.1128/JB.01481-06.
9. Galhardo RS, Rocha RP, Marques MV, Menck CFM. 2005. An SOS-regulated operon involved in damage-inducible mutagenesis in Caulobacter crescentus. Nucleic Acids Res 33:2603-2614. https://doi.org/10.1093/nar/gki551.
10. Henderson-Begg SK, Livermore DM, Hall LMC. 2006. Effect of subinhibitory concentrations of antibiotics on mutation frequency in Streptococcus pneumoniae. J Antimicrob Chemother 57:849-854. https://doi.org/10.1093/jac/dkl064.
11. Thi Do T, López E, Rodríguez-Rojas A, Rodríguez-Beltrán J, Couce A, Guelfo JR, Castañeda-García A, Blázquez J. 2011. Effect of recA inactivation on mutagenesis of Escherichia coli exposed to sublethal concentrations of antimicrobials. J Antimicrob Chemother 66:531-538. https://doi.org/10.1093/jac/dkq496.
12. Damron FH, McKenney ES, Barbier M, Liechti GW, Schweizer HP, Goldberg JB. 2013. Construction of mobilizable mini-Tn7 vectors for bioluminescent detection of gram-negative bacteria and single-copy promoter lux reporter analysis. Appl Environ Microbiol 79:4149-4153. https://doi.org/10.1128/AEM.00640-13.
13. Krause KM, Serio AW, Kane TR, Connolly LE. 2016. Aminoglycosides: an overview. Cold Spring Harb Perspect Med 6:a027029. https://doi.org/10.1101/cshperspect.a027029.
14. Fourmy D, Recht MI, Blanchard SC, Puglisi JD. 1996. Structure of the A site of Escherichia coli 16S ribosomal RNA complexed with an aminoglycoside antibiotic. Science 274:1367-1371. https://doi.org/10.1126/science.274.5291.1367.
15. Borovinskaya MA, Pai RD, Zhang W, Schuwirth BS, Holton JM, Hirokawa G, Kaji H, Kaji A, Cate JHD. 2007. Structural basis for aminoglycoside inhibition of bacterial ribosome recycling. Nat Struct Mol Biol 14:727-732. https://doi.org/10.1038/nsmb1271.
16. Odds FC. 2003. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 52:1. https://doi.org/10.1093/jac/dkg301.
17. Clinical and Laboratory Standards Institute. 2015. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard - 10th ed. CLSI document M07-A10. Clinical and Laboratory Standards Institute, Wayne, PA.
18. Breidenstein EBM, Bains M, Hancock REW. 2012. Involvement of the lon protease in the SOS response triggered by ciprofloxacin in Pseudomonas aeruginosa PAO1. Antimicrob Agents Chemother 56:2879-2887. https://doi.org/10.1128/AAC.06014-11.
19. Aranda J, Bardina C, Beceiro A, Rumbo S, Cabral MP, Barbe J, Bou G. 2011. Acinetobacter baumannii RecA protein in repair of DNA damage, antimicrobial resistance, general stress response, and virulence. J Bacteriol 193:3740-3747. https://doi.org/10.1128/JB.00389-11.
20. Singh R, Ledesma KR, Chang KT, Tam VH. 2010. Impact of recA on levofloxacin exposure-related resistance development. Antimicrob Agents Chemother 54:4262-4268. https://doi.org/10.1128/AAC.00168-10.
21. Alexeyev MF. 1999. The pKNOCK series of broad-host-range mobilizable suicide vectors for gene knockout and targeted DNA insertion into the chromosome of Gram-negative bacteria. Biotechniques 26:824-826.
22. Baharoglu Z, Krin E, Mazel D. 2013. RpoS plays a central role in the SOS induction by sub-lethal aminoglycoside concentrations in Vibrio cholerae. PLoS Genet 9:e1003421. https://doi.org/10.1371/journal.pgen.1003421.
23. Baharoglu Z, Mazel D. 2011. Vibrio cholerae triggers SOS and mutagenesis in response to a wide range of antibiotics: a route towards multiresistance. Antimicrob Agents Chemother 55:2438-2441. https://doi.org/10.1128/AAC.01549-10.
24. Peng Q, Zhou S, Yao F, Hou B, Huang Y, Hua D, Zheng Y, Qian Y. 2011. Baicalein suppresses the SOS response system of Staphylococcus aureus induced by ciprofloxacin. Cell Physiol Biochem 28:1045-1050. https://doi.org/10.1159/000335791.
25. Bellio P, Brisdelli F, Perilli M, Sabatini A, Bottoni C, Segatore B, Setacci D, Amicosante G, Celenza G. 2014. Curcumin inhibits the SOS response induced by levofloxacin in Escherichia coli. Phytomedicine 21:430-434. https://doi.org/10.1016/j.phymed.2013.10.011.
26. Nautiyal A, Patil KN, Muniyappa K. 2014. Suramin is a potent and selective inhibitor of Mycobacterium tuberculosis RecA protein and the SOS response: RecA as a potential target for antibacterial drug discovery. J Antimicrob Chemother 69:1834-1843. https://doi.org/10.1093/jac/dku080.
27. Jara LM, Pérez-Varela M, Corral J, Arch M, Cortés P, Bou G, Aranda J, Barbé J. 2015. Novobiocin inhibits the antimicrobial resistance acquired through DNA damage-induced mutagenesis in Acinetobacter baumannii. Antimicrob Agents Chemother 60:637-639. https://doi.org/10.1128/AAC.01810-15.
28. Schröder W, Goerke C, Wolz C. 2013. Opposing effects of aminocoumarins and fluoroquinolones on the SOS response and adaptability in Staphylococcus aureus. J Antimicrob Chemother 68:529-538. https://doi.org/10.1093/jac/dks456.
29. Lee AM, Ross CT, Zeng BB, Singleton SF. 2005. A molecular target for suppression of the evolution of antibiotic resistance: inhibition of the Escherichia coli RecA protein by N(6)-(1-naphthyl)-ADP. J Med Chem 48:5408-5411. https://doi.org/10.1021/jm050113z.
30. Possoz C, Newmark J, Sorto N, Sherratt DJ, Tolmasky ME. 2007. Sublethal concentrations of the aminoglycoside amikacin interfere with cell division without affecting chromosome dynamics. Antimicrob Agents Chemother 51:252-256. https://doi.org/10.1128/AAC.00892-06.
31. Sood P, Mandal A, Mishra B. 2000. Postantibiotic effect of a combination of antimicrobial agents on Pseudomonas aeruginosa. Chemotherapy 46:173-176. https://doi.org/10.1159/000007274.
32. Drago L, De Vecchi E, Nicola L, Colombo A, Guerra A, Gismondo MR. 2004. Activity of levofloxacin and ciprofloxacin in combination with cefepime, ceftazidime, imipenem, piperacillin-tazobactam and amikacin against different Pseudomonas aeruginosa phenotypes and Acinetobacter spp. Chemotherapy 50:202-210. https://doi.org/10.1159/000081033.
33. Gad GF, Mohamed HA, Ashour HM. 2011. Aminoglycoside resistance rates, phenotypes, and mechanisms of Gram-negative bacteria from infected patients in upper Egypt. PLoS One 6:e17224. https://doi.org/10.1371/journal.pone.0017224.